Tumor-infiltrating immune cell subpopulations influence the oncologic outcome after intravesical Bacillus Calmette-Guérin therapy in bladder cancer.
about
Intratumoral Th2 predisposition combines with an increased Th1 functional phenotype in clinical response to intravesical BCG in bladder cancer.Increased expression of long non-coding RNA CCEPR is associated with poor prognosis and promotes tumorigenesis in urothelial bladder carcinomaPD-L1 expression in bladder cancer and metastasis and its influence on oncologic outcome after cystectomyAssessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract CaRegulatory T Cells and Tumor-Associated Macrophages in the Tumor Microenvironment in Non-Muscle Invasive Bladder Cancer Treated with Intravesical Bacille Calmette-Guérin: A Long-Term Follow-Up Study of a Japanese Cohort.Synthesis of a Cleaved Form of Osteopontin by THP-1 Cells and Its Alteration by Phorbol 12-Myristate 13-Acetate and BCG Infection.Unwrapping the genomic characteristics of urothelial bladder cancer and successes with immune checkpoint blockade therapy.High IDO-1 expression in tumor endothelial cells is associated with response to immunotherapy in metastatic renal cell carcinoma.High expression of B7-H3 and CD163 in cancer tissues indicates malignant clinicopathological status and poor prognosis of patients with urothelial cell carcinoma of the bladder.Prognostic roles of tumor associated macrophages in bladder cancer: a system review and meta-analysis.Enhanced expression of PD-L1 in non-muscle-invasive bladder cancer after treatment with Bacillus Calmette-GuerinImmunology, Immunotherapy, and Translating Basic Science into the Clinic for Bladder Cancer
P2860
Q37712742-127113B2-0352-4015-A1E2-421C61132D94Q41279969-4A7C0C27-3061-40DA-8471-291A9108CA34Q42366515-020F2E39-814F-4715-8FDF-6BAE24B8C880Q46540302-DE81A02F-252A-442E-9469-D897633F5C42Q47105909-1F942B38-754B-4DE4-8A35-D171724F9BB4Q47551185-4F2EA1F4-9A0E-47BB-8D98-393D57673779Q49865882-3AD3B4AA-C755-49ED-A699-8D45D321A1E9Q52677218-911C1706-22DE-4524-B91D-4B153FA47D04Q54973593-83BFDCB5-56E3-49DC-9B8B-EA04606DCFF5Q55249861-6BC36694-6056-45D6-9BD3-3E3B0E3DCC69Q57821559-91C73A0E-8F8D-4A64-BC03-09F57A3C7746Q58705140-90887400-4BDA-49C0-AFF9-E15BB0D7D9E6
P2860
Tumor-infiltrating immune cell subpopulations influence the oncologic outcome after intravesical Bacillus Calmette-Guérin therapy in bladder cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 May 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Tumor-infiltrating immune cell ...... rin therapy in bladder cancer.
@en
Tumor-infiltrating immune cell ...... rin therapy in bladder cancer.
@nl
type
label
Tumor-infiltrating immune cell ...... rin therapy in bladder cancer.
@en
Tumor-infiltrating immune cell ...... rin therapy in bladder cancer.
@nl
prefLabel
Tumor-infiltrating immune cell ...... rin therapy in bladder cancer.
@en
Tumor-infiltrating immune cell ...... rin therapy in bladder cancer.
@nl
P2093
P2860
P356
P1433
P1476
Tumor-infiltrating immune cell ...... rin therapy in bladder cancer.
@en
P2093
Andrea Brunner
Claudia Zavadil
Georg Schäfer
Renate Pichler
Zoran Culig
P2860
P304
39916-39930
P356
10.18632/ONCOTARGET.9537
P407
P50
P577
2016-05-21T00:00:00Z